BSW
TMO icon

Buckingham Strategic Wealth’s Thermo Fisher Scientific TMO Stock Holding History

Buckingham Strategic Wealth’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		$3.54M Buy
6,402
+288
+5% +$165K 0.04% 176
2024
Q1 		$3.55M Buy
6,114
+179
+3% +$100K 0.04% 177
2023
Q4 		$3.15M Buy
5,935
+277
+5% +$134K 0.04% 183
2023
Q3 		$2.86M Sell
5,658
-99
-2% -$52.8K 0.04% 179
2023
Q2 		$3M Buy
5,757
+242
+4% +$131K 0.04% 175
2023
Q1 		$3.04M Hold
5,515
– – 0.06% 145
2022
Q4 		$3.04M Sell
5,515
-663
-11% -$351K 0.06% 145
2022
Q3 		$3.13M Buy
6,178
+276
+5% +$154K 0.06% 134
2022
Q2 		$3.21M Buy
5,902
+28
+0.5% +$15.4K 0.06% 137
2022
Q1 		$3.47M Sell
5,874
-265
-4% -$152K 0.07% 133
2021
Q4 		$4.1M Sell
6,139
-515
-8% -$322K 0.08% 118
2021
Q3 		$3.8M Buy
6,654
+232
+4% +$127K 0.08% 122
2021
Q2 		$3.24M Buy
6,422
+180
+3% +$84.9K 0.08% 135
2021
Q1 		$2.85M Sell
6,242
-569
-8% -$272K 0.14% 124
2020
Q4 		$3.17M Buy
6,811
+5,355
+368% +$2.51M 0.17% 111
2020
Q3 		$643K Sell
1,456
-185
-11% -$76.4K 0.05% 227
2020
Q2 		$595K Sell
1,641
-844
-34% -$283K 0.06% 195
2020
Q1 		$705K Sell
2,485
-37
-1% -$11.7K 0.07% 209
2019
Q4 		$819K Sell
2,522
-30
-1% -$9.1K 0.08% 185
2019
Q3 		$743K Buy
2,552
+25
+1% +$7.16K 0.08% 179
2019
Q2 		$742K Buy
2,527
+421
+20% +$116K 0.08% 184
2019
Q1 		$576K Buy
2,106
+136
+7% +$33.8K 0.07% 203
2018
Q4 		$441K Sell
1,970
-638
-24% -$150K 0.07% 202
2018
Q3 		$637K Buy
2,608
+1,331
+104% +$306K 0.1% 159
2018
Q2 		$265K Buy
1,277
+206
+19% +$43.7K 0.04% 286
2018
Q1 		$221K Buy
+1,071
New +$225K 0.04% 281

Other funds holding TMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Buckingham Strategic Wealth's TMO Position: Q2 2024 in Review

Buckingham Strategic Wealth increased its Thermo Fisher Scientific (TMO) stake by 4.7% in Q2 2024, buying an estimated $165K and bringing the position to 6,402 shares worth $3.54M. The position accounts for 0.04% of the portfolio, ranked #176.

Buckingham Strategic Wealth first reported a position in TMO in Q1 2018 and has held it in 26 quarters since. The position peaked at $4.1M in Q4 2021. 2,542 funds tracked by Wall St. Rank hold TMO as of Q2 2024.

  • Buckingham Strategic Wealth held 6,402 shares of Thermo Fisher Scientific worth $3.54M as of Q2 2024.
  • Buckingham Strategic Wealth bought 288 Thermo Fisher Scientific shares in Q2 2024, an estimated $165K.
  • Thermo Fisher Scientific made up 0.04% of Buckingham Strategic Wealth's portfolio in Q2 2024, its #176 holding.
  • Buckingham Strategic Wealth first reported a position in Thermo Fisher Scientific in Q1 2018 and has held it in 26 quarters since.
  • Buckingham Strategic Wealth's Thermo Fisher Scientific position peaked at $4.1M in Q4 2021.
  • 2,542 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2024.

Based on Buckingham Strategic Wealth's 13F filing for Q2 2024, filed 12 Aug 2024.